Your browser doesn't support javascript.
Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID-19 pandemic, now and in the future.
Mok, Vincent C T; Pendlebury, Sarah; Wong, Adrian; Alladi, Suvarna; Au, Lisa; Bath, Philip M; Biessels, Geert Jan; Chen, Christopher; Cordonnier, Charlotte; Dichgans, Martin; Dominguez, Jacqueline; Gorelick, Philip B; Kim, SangYun; Kwok, Timothy; Greenberg, Steven M; Jia, Jianping; Kalaria, Rajesh; Kivipelto, Miia; Naegandran, Kandiah; Lam, Linda C W; Lam, Bonnie Yin Ka; Lee, Allen T C; Markus, Hugh S; O'Brien, John; Pai, Ming-Chyi; Pantoni, Leonardo; Sachdev, Perminder; Skoog, Ingmar; Smith, Eric E; Srikanth, Velandai; Suh, Guk-Hee; Wardlaw, Joanna; Ko, Ho; Black, Sandra E; Scheltens, Philip.
  • Mok VCT; Department of Medicine and Therapeutics, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, New Territories, Shatin, Hong Kong SAR, China.
  • Pendlebury S; Gerald Choa Neuroscience Centre, Margaret K. L. Cheung Research Centre for Management of Parkinsonism, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
  • Wong A; Li Ka Shing Institute of Health Sciences, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Alladi S; NIHR Oxford Biomedical Research Centre, The Joint Research Office, Oxford, UK.
  • Au L; Departments of Acute General Medicine and Geratology, John Radcliffe Hospital, Oxford, UK.
  • Bath PM; Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
  • Biessels GJ; Department of Medicine and Therapeutics, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, New Territories, Shatin, Hong Kong SAR, China.
  • Chen C; Gerald Choa Neuroscience Centre, Margaret K. L. Cheung Research Centre for Management of Parkinsonism, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
  • Cordonnier C; Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, India.
  • Dichgans M; Department of Medicine and Therapeutics, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, New Territories, Shatin, Hong Kong SAR, China.
  • Dominguez J; Gerald Choa Neuroscience Centre, Margaret K. L. Cheung Research Centre for Management of Parkinsonism, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
  • Gorelick PB; Stroke Trials Unit, Division of Clinical Neuroscience, School of Medicine, The University of Nottingham, Nottingham, UK.
  • Kim S; Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Kwok T; Department of Pharmacology, Memory Aging and Cognition Centre, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Greenberg SM; Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France.
  • Jia J; Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
  • Kalaria R; German Center for Neurodegenerative Diseases (DZNE, Munich), Munich, Germany.
  • Kivipelto M; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
  • Naegandran K; Memory Center, International Institute for Neurosciences, St. Luke's Medical Center, Manila, Philippines.
  • Lam LCW; The Ken & Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Lam BYK; Division of Cerebrovascular Disease and Neurocritical Care, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Lee ATC; Department of Translational Neuroscience, College of Human Medicine, Michigan State University, Grand Rapids, Michigan, USA.
  • Markus HS; Department of Neurology, Seoul National University College of Medicine, Clinical Neuroscience Center, Seoul National University Bundang Hospital, Seoul, South Korea.
  • O'Brien J; Division of Geriatrics, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
  • Pai MC; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Pantoni L; Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Sachdev P; Translational and Clinical Research Institute, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, UK.
  • Skoog I; Karolinska Institutet, Dept NVS, Division of Clinical Geriatrics, Center for Alzheimer Research and Karolinska University Hospital, Theme Aging, Stockholm, Sweden.
  • Smith EE; Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
  • Srikanth V; Ageing and Epidemiology (AGE) Research Unit, School of Public Health, Imperial College London, London, UK.
  • Suh GH; Department of Neurology, National Neuroscience Institute, Singapore.
  • Wardlaw J; Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, New Territories, Shatin, Hong Kong SAR, China.
  • Ko H; Department of Medicine and Therapeutics, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, New Territories, Shatin, Hong Kong SAR, China.
  • Black SE; Gerald Choa Neuroscience Centre, Margaret K. L. Cheung Research Centre for Management of Parkinsonism, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
  • Scheltens P; Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, New Territories, Shatin, Hong Kong SAR, China.
Alzheimers Dement ; 16(11): 1571-1581, 2020 11.
Article in English | MEDLINE | ID: covidwho-713873
ABSTRACT
We have provided an overview on the profound impact of COVID-19 upon older people with Alzheimer's disease and other dementias and the challenges encountered in our management of dementia in different health-care settings, including hospital, out-patient, care homes, and the community during the COVID-19 pandemic. We have also proposed a conceptual framework and practical suggestions for health-care providers in tackling these challenges, which can also apply to the care of older people in general, with or without other neurological diseases, such as stroke or parkinsonism. We believe this review will provide strategic directions and set standards for health-care leaders in dementia, including governmental bodies around the world in coordinating emergency response plans for protecting and caring for older people with dementia amid the COIVD-19 outbreak, which is likely to continue at varying severity in different regions around the world in the medium term.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Dementia / Alzheimer Disease Type of study: Prognostic study Topics: Long Covid Limits: Aged / Female / Humans / Male Language: English Journal: Alzheimers Dement Year: 2020 Document Type: Article Affiliation country: Alz.12143

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Dementia / Alzheimer Disease Type of study: Prognostic study Topics: Long Covid Limits: Aged / Female / Humans / Male Language: English Journal: Alzheimers Dement Year: 2020 Document Type: Article Affiliation country: Alz.12143